The proposal would eliminate health-plan-run PBMs in Medicaid and establish a single state-contracted PBM, a move supporters ...
As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
President Trump's nominee for health secretary, Robert F. Kennedy Jr., was questioned harshly by both Democrats and ...
The Federal Trade Commission on Jan. 14 published a second interim staff report on the prescription drug middleman industry, ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
Grand Junction-Montrose KKCO on MSN1d
A new bipartisan House bill could help Coloradans with healthcare costsA bipartisan bill was introduced into the house this week regarding healthcare costs for Coloradans. The bill introduced by ...
At the Senate Finance nomination hearing yesterday, he declined to give a yes-or-no answer about Affordable Care Act tax credit rule renewal.
It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
Pharmacy Benefit Managers (PBM) sit in the center of our prescription drug system, coordinating between insurance companies, ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback